drugset / Trial / NCT05226442
Safety and Feasibility of Argatroban As Anticoagulant in Adults with ECMO
RandomizedParallel-groupOpen-labelTreatment
Summary
This prospective, randomized, controlled pilot trial aims to assess the safety and feasibility of Argatroban as an alternative anticoagulant to unfractionated heparin in patients receiving extracorporeal membrane oxygenation.
Timeline
- Start
- 2021-12-01
- Primary completion
- 2024-07-07
- Completion
- 2024-07-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Argatroban | Small molecule | 0.3 ug/kg | — |
| Comparator | Heparin | Other / unclassified | — | — |